MedPath

Light Sleep: Screen Use and Sleep Health

Not Applicable
Completed
Conditions
Glasses
Interventions
Device: Blue light-blocking glasses
Device: Glasses with clear lenses
Registration Number
NCT05342662
Lead Sponsor
Penn State University
Brief Summary

The Phone Sleep Study is being done to find out whether wearing blue light-blocking glasses in the evening improves subsequent sleep. This is a 21-day study and participants will be asked to wear a sleep-monitoring "actiwatch", a heart tracker, and an activity monitor, as well as to provide screenshots of participants' smartphone's screen time app for three weeks. Participants will also be asked to wear a blood pressure cuff on their arm for three days during each week, for a total of nine days.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  1. Fluent English speaker and reader
  2. Capable of providing one's own informed consent
  3. Age 18 to 29 years old
  4. Healthy, sighted individuals
  5. Own an iOS smartphone (iPhone)
  6. Willingness to update smartphone to access the current version of the Screen Time or StayFree application, depending on smartphone operating system
  7. Willingness to participate in surveys, wear health monitoring devices, and provide screenshots of their smartphone's screentime application throughout the entire study
Exclusion Criteria
  1. Younger than 18 or older than 29 years
  2. Individuals who are blind or wear corrective lenses
  3. Taking prescribed medications that affect sleep
  4. Recent shift work
  5. Sleep disorder diagnosis or any cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Blue light-blocking glassesBlue light-blocking glassesParticipants will wear blue light-blocking glasses to evaluate whether sleep behaviors improve.
Glasses with clear lensesGlasses with clear lensesParticipants will wear glasses with clear lenses to serve as the control condition.
Primary Outcome Measures
NameTimeMethod
Sleep midpointThroughout the duration of the study (~3 weeks)

Midnight-centered clocktime denoting the middle of the nocturnal sleep episode

Total sleep time at nightThroughout the duration of the study (~3 weeks)

Length of time spent asleep during the night, excluding time spent awake throughout the sleep episode

Sleep onsetThroughout the duration of the study (~3 weeks)

Midnight-centered clocktime of when participant falls asleep at night

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Biobehavioral Health Building

🇺🇸

University Park, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath